Dr. Martens, the iconic Northamptonshire footwear brand, has cut its pre-tax losses, with its CEO “confident in [the business’s] plans for the year.”
In first half results for the 26 weeks ended 28 September 2025, Dr. Martens posted a pre-tax loss of £11m, an improvement on a £28.7m loss in the same period last year.
This came while revenue dropped to £322m from £324.6m, with the best performing region being the Americas, with revenue up 6% constant currency. Meanwhile EMEA revenue declined 3% constant currency, and APAC revenue grew 2% constant currency.
Ije Nwokorie, CEO, said: “As we set out in June, we’re pivoting from a channel-first to a consumer-first strategy. Our brand is strong, as evidenced by the 33% increase in shoes volumes and the successful launch of new products such as the Zebzag Laceless boot and the 1460 Rain boot. While it’s still early days, we are happy with the advances we’re making and are seeing green shoots across each of our four Levers for Growth.
“This strategic progress, as well as the benefits from the cost action plan delivered last year and our continued focus on cost management, is delivering a meaningful improvement in our financial performance including a continued reduction in net bank debt.
“While the marketplace remains uncertain and consumers are cautious, and our biggest trading weeks are ahead, we are confident in our plans for the year. I am laser-focused on execution and setting the business up for growth in the coming years. I’d like to thank every member of the Dr. Martens team, as well as our partners around the world, for their continued hard work and passionate commitment in this endeavour.”
